Please rate this video

COSTEM 2019 | Can third party CMV-specific T-cells replace drug therapy?

Please rate this video

Catherine Bollard

Catherine Bollard, MD, MBChB, Children’s National Medical Center, Washington, DC, discusses the possibility of third party CMV-specific T-cells replacing drug therapy. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter